Study identifies shared pathway driving cardiac fibrosis
Three adenosine receptor subtypes that normally send different signals were found to converge on a common pathway that…
Baseline liver fibrosis severity predicts treatment response in patients with HBeAg-positive CHB
Background and aims The impact of baseline liver fibrosis severity on the effectiveness of pegylated interferon (Peg-IFN) combined…
Could scorpion venom inspire new treatments for liver disease?
From blocking inflammatory immune pathways to disrupting hepatitis viruses, scorpion-derived peptides are attracting attention as potential drug candidates,…
Specialized blood vessel cells found to actively drive lung fibrosis
Millions of people worldwide are affected by diseases that cause scarring of the lungs, often leading to breathing…
Using DNA sequencing for accurate identification of microbial infections in cystic fibrosis patients
Lung infections are a constant risk for people living with cystic fibrosis (CF), a life-threatening genetic disorder which…
Daily tomatoes lowered a key marker of liver fat in MASLD trial
A six-week tomato-rich diet outperformed a tomato-free diet on an important marker of hepatic steatosis, pointing to a…
Traditional Japanese medicine for obesity may help reduce age-related tissue fibrosis
A traditional Japanese medicine used for obesity may do more than support weight loss. Researchers at the University…
AI-powered blood test detects liver cancer across distinct populations
Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer…
Study reveals unexpected mechanism driving extreme antibiotic resistance
A patient with a severe infection is prescribed a potent antibiotic. Hopes for improvement are high, but just…
Study tests chronotype’s liver link and finds no significant association
A small Italian study tested whether an individual’s preferred daily schedule aligns with hidden liver changes, but found…
Discovery of lung protein offers hope for pulmonary fibrosis
Pulmonary fibrosis is a deadly disease where scar tissue grows in the lungs, making breathing more difficult. Approximately 2,170 Australians are diagnosed annually with…
Monoclonal antibody shows promise for treating acute respiratory distress syndrome
Doctors have few options for patients who develop a life-threatening lung condition called acute respiratory distress syndrome, or…